![A prospective randomized controlled trial of Q‐switched Nd:YAG laser with topical 3% tranexamic acid (TA) versus microneedling with topical 3% tranexamic acid (TA) in treatment of melasma - Debasmita - 2022 - A prospective randomized controlled trial of Q‐switched Nd:YAG laser with topical 3% tranexamic acid (TA) versus microneedling with topical 3% tranexamic acid (TA) in treatment of melasma - Debasmita - 2022 -](https://onlinelibrary.wiley.com/cms/asset/5604fc65-01bb-486b-a289-73a573c51f88/jocd14532-fig-0002-m.jpg)
A prospective randomized controlled trial of Q‐switched Nd:YAG laser with topical 3% tranexamic acid (TA) versus microneedling with topical 3% tranexamic acid (TA) in treatment of melasma - Debasmita - 2022 -
![Q-PTP is an optimized technology of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the laser therapy of melasma: A prospective split-face study Q-PTP is an optimized technology of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the laser therapy of melasma: A prospective split-face study](https://www.spandidos-publications.com/article_images/ol/18/4/ol-18-04-4136-g02.jpg)
Q-PTP is an optimized technology of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the laser therapy of melasma: A prospective split-face study
![Results before (A) and after (B) the Q-switched Nd:YAG laser (Medlite... | Download Scientific Diagram Results before (A) and after (B) the Q-switched Nd:YAG laser (Medlite... | Download Scientific Diagram](https://www.researchgate.net/publication/224940428/figure/fig2/AS:195889651032065@1423715140106/Results-before-A-and-after-B-the-Q-switched-NdYAG-laser-Medlite-II-Conbio.png)